Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Boehringer Ingelheim
Merck
AstraZeneca
Express Scripts

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Fosinopril Sodium And Hydrochlorothiazide patents expire, and when can generic versions of Fosinopril Sodium And Hydrochlorothiazide launch?

Fosinopril Sodium And Hydrochlorothiazide is a drug marketed by Ani Pharms Inc, Aurobindo Pharma, Emcure Pharms Ltd, Invagen Pharms, Mylan, Sandoz, Sun Pharm Inds Ltd, and Teva. and is included in nine NDAs.

The generic ingredient in FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE is fosinopril sodium; hydrochlorothiazide. There are six drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the fosinopril sodium; hydrochlorothiazide profile page.

Summary for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Drug patent expirations by year for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE
Recent Clinical Trials for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ranbaxy Laboratories LimitedN/A

See all FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE clinical trials

Pharmacology for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

US Patents and Regulatory Information for FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076608-001 Dec 3, 2004 DISCN No No   Start Trial   Start Trial   Start Trial
Teva FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 076945-002 Jul 5, 2006 DISCN No No   Start Trial   Start Trial   Start Trial
Emcure Pharms Ltd FOSINOPRIL SODIUM AND HYDROCHLOROTHIAZIDE fosinopril sodium; hydrochlorothiazide TABLET;ORAL 079025-001 Sep 17, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Mallinckrodt
Boehringer Ingelheim
Merck
AstraZeneca
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.